KENILWORTH, N.J.–(BUSINESS WIRE) December 20, 2019 –Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Ervebo® (Ebola Zaire Vaccine, Live)…Original Article
FDA Approves Ervebo (Ebola Zaire Vaccine, Live) for the Prevention of Disease Caused by Zaire Ebolavirus
